Skin Health
for Primary Care Providers (PCPs)
1 Room. 20 Programs. 100% Medicare Eligible.
Skin Health
for Primary Care Providers (PCPs)
Skin Cancers
DTC Skin Care Clinics® Early detection of skin cancer is essential in Primary Care Physician (PCP) clinics to identify malignant lesions before they progress. DTC Skin Cancer Care Clinics® utilize AI-powered tools like DermaSensor, a non-invasive, FDA-registered device that enables rapid, point-of-care skin lesion analysis.
This handheld technology delivers objective results in seconds NOT days, helping PCPs detect risk early and decide when further dermatologic evaluation is needed. Seamlessly integrating into the clinical workflow, it supports earlier diagnosis, improves patient outcomes, and reduces unnecessary referrals—bringing dermatologic insight directly into primary care.
Before...
Your skin becomes a battle of life and death,
there’s hope for early detection at DTC.
Skin healthcare is medically managed to supports skin function both inside and out for the overall lasting health.
"For me, it (DermaSensor) was a no-brainer to choose the device... it’s crucial to recognize that skin cancers do not always present the same way in people of color."
Dr. Jessica Shepherd MD, MBA, FACOG Renowned Gynecologist and Good Morning America Media Personality
🌺 Exosomes Topical
13:13 Minutes
Note: 15-second audio delay after pressing play.
DermaSensor™ – The Future of Skin Cancer Detection at the Point of Care
At Diabetes Testing Centers™ (DTC), we Go Beyond Diabetes Care to help medical providers identify health risks early—before they become life-altering. DermaSensor™ aligns with our mission by delivering a fast, non-invasive, and reimbursable way to screen for skin cancer in any clinical setting.
Why Skin Cancer Screening Matters for Every Provider
Skin cancer is the most common cancer in the United States, with over 5 million cases diagnosed annually. Early detection is critical—and often life-saving. Yet, access to dermatology remains limited, and many suspicious lesions go unexamined.
Primary care physicians, OB/GYNs, concierge providers, and urgent care centers are in a unique position to identify high-risk skin lesions during routine exams—but often lack the tools or training to do so confidently. DermaSensor™ fills that gap.
What Is DermaSensor™?
DermaSensor™ is the first FDA-cleared, non-invasive skin cancer detection device designed specifically for frontline healthcare providers. Using advanced Elastic Scattering Spectroscopy (ESS) and proprietary machine learning algorithms, the device evaluates cellular structure and generates a risk classification in under 30 seconds.
No Scalpels. No Pathology. No Result-Related Anxieties.
Elastic Scattering Spectroscopy (ESS) and Artificial Intelligence (AI) analyzes how light interacts with cellular structures to detect abnormalities of skin lesions for early cancer detection.
Ideal for These Clinical Settings:
Primary Care & Family Medicine
OB/GYN Practices (skin checks during annual exams)
Concierge & Direct Primary Care Clinics
Medical Aesthetics & Med Spas (pre-procedure risk evaluation)
Health Systems & ACOs (value-based care + preventive metrics)
Urgent Care & Walk-In Clinics (spot-checks for acute concerns)
Workflow Efficiency & Staff-Friendly Design
DermaSensor™ is engineered for simplicity and speed:
Test takes less than 1 minute from start to finish
No additional staff required—can be performed by the provider or trained MA
Results available in real-time during the patient visit
Reduces administrative time by eliminating biopsy referrals
Includes onboarding, protocol training, and billing guidance
Differentiate Your Clinic Without Adding Costly Complexity
You don’t need to become a dermatologist to catch skin cancer early. DermaSensor™ allows your clinic to:
Expand your clinical value proposition
Offer preventive cancer screening in-house
Retain patients who might otherwise be referred out
Enhance your role in total patient care and risk stratification
Referral & Patient Retention Opportunities
Patients feel safer and more confident when skin checks are part of their routine visit
Providers can catch lesions early—before they require surgery or lead to metastatic disease
Clinics offering DermaSensor™ become known as comprehensive, proactive, and tech-forward in their communities
Why DTC Recommends DermaSensor™
At DTC, we believe that every primary care and frontline provider should have access to the tools that make life-saving screenings simple, fast, and financially viable.
DermaSensor™ represents the future of preventive medicine—portable, intelligent, reimbursable, and patient-friendly.
AI Devices Elevate PCP Clinics
DermaSensor™ detects the three most common skin cancers in seconds.
Cutting-Edge Technology
Key Features & Clinical Benefits
FDA-Cleared for adults with suspicious skin lesions
Screens for Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma
Non-invasive – no biopsy, no prep, no aftercare
Safe for all skin tones (Fitzpatrick Types I–VI)
AI-powered classification for enhanced clinical decision-making
Generates objective risk reports in seconds
Can be performed during Annual Wellness Visits (AWVs)
We can help your clinic:
Schedule a virtual product demo
Receive workflow integration support
Access provider marketing kits and patient education tools
Join a priority referral network with other clinics using DermaSensor™
Contact DTC today to see how you can bring skin cancer detection into your exam room—without disrupting your schedule, staff, or bottom line.
Detect Skin Cancer—In Seconds, Not Weeks or Months.
No Cutting. No Waiting. No Kidding.